In 2005, Timothy et al. found that L-histidine (1) (compound 1–11 in Table 1) at a concentration that is not harmful to cells can inhibit the motility stimulation of ATX on two tumor cell lines from human melanoma (A2058) and human ovarian cancer (SKOV-3). Here, ENPP2 is linked to melanoma.